Condition
Pseudophakic Corneal Edema
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Corneas Assigned By Donor Age Group
Research Leaders
15 sponsors active, led by Midwest Eye Banks
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Research Network
Common Treatments
- Corneas Assigned By Donor Age Group1
Active Sponsors
- Midwest Eye Banks1
- Tissue Banks International1
- ViroMed Laboratories, Inc.1
- Vision Share, Inc.1
- Bausch & Lomb Incorporated1
Top Investigators
University of Cincinnati and Cincinnati Eye Institute
Jaeb Center for Health Research
(PI of Specular Microscopy Ancillary Study), Case Western Reserve University and University Hospitals Case Medical Center
University of California, Davis
Related Conditions
- Fuchs Dystrophy1
- Corneal Disease1